Articles by joefner@cytokinesociety.org

Special Article of Interest

What’s new in translational immunology

May 6, 2023

The last several years have seen a virtual explosion of novel inborn errors of immunity (IEI), with 56 novel diseases discovered between 2020-2022 1. It should therefore come as no surprise that the spectrum of genetic immune dysregulation has continued to expand dramatically over the last year. While it is impossible to review all the major advances in the field, several recent publications will be of particular interest to cytokine biologists [READ MORE]

President's Letter

A NOTE FROM THE ICIS PRESIDENT, Christopher Hunter:

May 6, 2023

With only 4.5 months till our Annual Meeting in Athens this would be a great time to encourage Early-Bird registrations (June 28th deadline) and Late Breaking abstract submissions (deadline August 31st) and we remain dedicated to providing support for our trainees. The organizers invited speakers program has come along nicely – but abstracts remain an important source of the speakers chosen and they will be included in the program in the coming days. It is also our awards season – and this year we had an exceptional slate of candidates for our Senior & Mid-Career awards (Judy Lieberman, Daniel Cua, Dusan Bogunovic, Jacob Yount, Daniela Novick and Brendan Jenkins), while we have had a record number of nominees for the junior awards (to be announced soon). Important opportunity to acknowledge those who took the time to nominate these candidates and the work of our awards committee in assessing these amazing cytokine biologists. [READ MORE]

New Member Mini-Bios

Larissa Laine

May 6, 2023

Larissa Laine, PhD, Finnish institute for Health and Welfare, Expert Microbiology Unit, Helsinki, Finland Larissa Laine, Ph.D Dr. Laine received her Ph.D in parasitology and biochemistry from the University of Glasgow, Scotland, United Kingdom. She studied the biochemical, structural, and functional properties of the Plasmodium falciparum pyruvate dehydrogenase complex. She [READ MORE]

New Member Mini-Bios

Ahmed Kabil

May 6, 2023

Ahmed Kabil, University of British Columbia, Biomedical Research Centre, McNagny Lab, Vancouver, Canada Ahmed Kabil is a PhD candidate working in the Biomedical Research Centre at the University of British Columbia. He obtained a high honors BASc in applied science from the University of Toronto. Ahmed Kabil’s research focuses on [READ MORE]

Reviews of Interest

Reviews of Interest

May 5, 2023

April 17, 2024 – Reviews of Interest PMID: 37726402 Anti-cytokine autoantibodies: mechanistic insights and disease associations. Cheng A, Holland SM. Nat Rev Immunol. 2024 Mar;24(3):161-177. doi: 10.1038/s41577-023-00933-2. Epub 2023 Sep 19.PMID: 37726402 Review. This review provides a comprehensive overview of the emerging field of anti-cytokine autoantibodies (ACAA), including their pathological [READ MORE]

Reviews of Interest

COVID-19 special collection

May 5, 2023

COVID-19 special: PMID: 36198912 COVID-19 and cellular senescence. Schmitt CA, Tchkonia T, Niedernhofer LJ, Robbins PD, Kirkland JL, Lee S. Nat Rev Immunol. 2022 Oct 5:1-13. doi: 10.1038/s41577-022-00785-2. Online ahead of print.PMID: 36198912 Free PMC article. Review.   PMID: 36631691 Innate immune evasion strategies of SARS-CoV-2. Minkoff JM, tenOever B. Nat Rev Microbiol. [READ MORE]

Members in the News

Scientific Director of Intramural Research, Dr. John O’Shea, Elected to the U.S. National Academy of Sciences

May 5, 2023

Scientific Director of Intramural Research, Dr. John O’Shea, Elected to the U.S. National Academy of Sciences On May 2, 2023, NIAMS Scientific Director of Intramural Research, Dr. John O’Shea, was elected to the U.S. National Academy of Sciences at the conclusion of the Academy’s 160th annual meeting. This designation – considered one of the [READ MORE]

Members in the News

Brendan Jenkins to join the University of Adelaide South Australian Immunogenomics Cancer Institute (SAiGENCI) as Program Leader in Tumour Inflammation and Immunotherapy

May 5, 2023

Professor Brendan Jenkins, Program Leader in Tumour Inflammation and Immunotherapy, SAiGENCI After 18 years at the Hudson Institute of Medical Research in Melbourne, Australia, the last 2 years as Centre Head (Centre for Innate Immunity and Infectious Diseases), Professor Brendan Jenkins has accepted a new and exciting position back in [READ MORE]

COVID-19 Special

COVID-19 Special

May 5, 2023

COVID-19 special: PMID: 36198912 COVID-19 and cellular senescence. Schmitt CA, Tchkonia T, Niedernhofer LJ, Robbins PD, Kirkland JL, Lee S. Nat Rev Immunol. 2022 Oct 5:1-13. doi: 10.1038/s41577-022-00785-2. Online ahead of print.PMID: 36198912 Free PMC article. Review. PMID: 36631691 Innate immune evasion strategies of SARS-CoV-2. Minkoff JM, tenOever B. Nat Rev Microbiol. 2023 [READ MORE]